Perfil
Founder of Neoleukin Therapeutics, Inc. and Ansible Marketing, Inc., Carl Walkey is former Senior Vice President-Corporate Development of Neoleukin Therapeutics, Inc.
Dr. Walkey received a doctorate from the University of Toronto.
Antiguos cargos conocidos de Carl Walkey.
Empresas | Cargo | Fin |
---|---|---|
NEUROGENE INC. | Founder | 01/12/2022 |
Ansible Marketing, Inc. | Founder | - |
Formación de Carl Walkey.
University of Toronto | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
Ansible Marketing, Inc. |